Rahma Mallek
YOU?
Author Swipe
View article: PB1749: COMPARATIVE STUDY OF B AND T-ALL IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS
PB1749: COMPARATIVE STUDY OF B AND T-ALL IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS Open
Topic: 2. Acute lymphoblastic leukemia - Clinical Background: Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. This tumor has a good prognosis with cure rates of more than 80%. Therefore, epidemiological and th…
View article: PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA
PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA Open
Topic: 33. Bleeding disorders (congenital and acquired) Background: Von Willebrand disease (VWD) is defined as a defective or dysfunctional Von Willebrand Factor (VWF) that mediates platelet adhesion and aggregation at vascular damage site…
View article: P398: HIGH-RISK CHILDHOOD AND ADOLESCENT AND YOUNG ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE EORTC 58951 PROTOCOL: RESULTS AND OUTCOME
P398: HIGH-RISK CHILDHOOD AND ADOLESCENT AND YOUNG ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE EORTC 58951 PROTOCOL: RESULTS AND OUTCOME Open
Background: More than 80% of children with acute lymphoblastic leukemia (ALL) can be cured, but subsets of patients have significantly worse outcomes. Improved supportive care and intensification of chemotherapy for the high-risk group of …
View article: PB1876: SIXTEEN YEARS OF EXPERIENCE WITH THE MRC-10 PROTOCOL FOR THE TREATMENT OF ADULT ACUTE MYELOID LEUKEMIA IN THE SOUTH OF TUNISIA
PB1876: SIXTEEN YEARS OF EXPERIENCE WITH THE MRC-10 PROTOCOL FOR THE TREATMENT OF ADULT ACUTE MYELOID LEUKEMIA IN THE SOUTH OF TUNISIA Open
Topic: 4. Acute myeloid leukemia - Clinical Background: Acute myeloid leukemia (AML) is a serious, but potentially curable hemopathy. Despite the progress of AML treatment in recent decades mainly due to the use of intensives therapies and…
View article: PB1907: EPIDEMIOLOGICAL PROFILE AND DIAGNOSTIC FEATURES OF ACUTE MYELOBLASTIC LEUKEMIA IN ADULTS: EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF SFAX
PB1907: EPIDEMIOLOGICAL PROFILE AND DIAGNOSTIC FEATURES OF ACUTE MYELOBLASTIC LEUKEMIA IN ADULTS: EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF SFAX Open
Topic: 4. Acute myeloid leukemia - Clinical Background: Acute myeloid leukemia (AML) is a group of malignant hemopathies genetically and phenotypically very heterogeneous. Identification of clinical and biological prognostic factors is ess…
View article: PB1891: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
PB1891: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA Open
Topic: 4. Acute myeloid leukemia - Clinical Background: Despite the improvement treatment in acute promyelocytic leukemia (APL), early death rate, 30 days following the diagnosis, remained higher (14 à 40%). Aims: We reported in this study…
View article: PB1895: CHARACTERISTICS AND OUTCOME OF PEADIATRIC ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
PB1895: CHARACTERISTICS AND OUTCOME OF PEADIATRIC ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA Open
Topic: 4. Acute myeloid leukemia - Clinical Background: Acute promyelocytic leukemia (APL) in children is rare, 5-10% of peadiatric acute myeloid leukemia. Aims: In this study, we present clinical and biological characteristics and outcome…
View article: PB2020: OUTCOMES OF PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES
PB2020: OUTCOMES OF PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES Open
Topic: 10. Myelodysplastic syndromes - Clinical Background: In high-risk myelodysplastic syndromes (MDS), the goal of therapy is to prolong survival and reduce the risk of transformation into acute leukemia, but only a few drugs are curren…
View article: PB1758 CHILDHOOD ACUTE MYELOID LEUKEMIA IN SOUTHERN TUNISIA: ABOUT 52 CASES
PB1758 CHILDHOOD ACUTE MYELOID LEUKEMIA IN SOUTHERN TUNISIA: ABOUT 52 CASES Open
Background: Childhood acute myeloid leukemia (AML) represents 20% of childhood acute leukemia. Despite major improvement in outcome, the prognostic is pejorative compared with childhood acute lymphoblastic leukemia. Aims: We report the cli…